Caris Life Sciences, Inc. (CAI)
14.55
-0.70
(-4.59%)
USD |
NASDAQ |
May 15, 16:00
14.75
+0.20
(+1.37%)
After-Hours: 20:00
Caris Life Sciences Shareholders Equity (Quarterly) : 593.49M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Neurocrine Biosciences, Inc. | 3.407B |
| Nuvalent, Inc. | 1.174B |
| Alnylam Pharmaceuticals, Inc. | 1.075B |
| Glaukos Corp. | 670.93M |
| CytomX Therapeutics, Inc. | 319.94M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.162B |
| Total Liabilities (Quarterly) | 568.90M |
| Debt to Equity Ratio | 0.7261 |
| Current Ratio | 7.048 |
| Net Debt Paydown Yield | -0.03% |